Showing results (781-790 of 1,188) with videos related to

Sort By:
Pageof 119
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2023
Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic SyndromesSung-Eun Lee, Feng Wang, Maison Grefe, et al.
The Lancet. Oncology|October 19, 2012
Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 studyHagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, et al.
Cancer|March 7, 2023
Association between bariatric surgery and outcomes in chronic myeloid leukemiaFadi G Haddad, Hagop M Kantarjian, Aram Bidikian, et al.
Leukemia|February 8, 2022
Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinibYuya Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
Blood|April 15, 2020
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover studyGuillermo Garcia-Manero, Elizabeth A Griffiths, David P Steensma, et al.
American Journal of Hematology|June 20, 2020
The clinical impact of time to response in de novo accelerated-phase chronic myeloid leukemiaMaro Ohanian, Hagop M Kantarjian, Mahran Shoukier, et al.
Biosensors & Bioelectronics|February 14, 2006
Point-of-care biosensor systems for cancer diagnostics/prognosticsSteven A Soper, Kathlynn Brown, Andrew Ellington, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 2006
HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic targetXin Han, Guillermo Garcia-Manero, Timothy J McDonnell, et al.
Epigenetics|August 29, 2020
Germline DNMT3A mutation in familial acute myeloid leukaemiaCourtney D DiNardo, Hannah C Beird, Marcos Estecio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 9, 2025
A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome MappingEduardo Edelman Saul, Samuel Urrutia, Hui Yang, et al.
Pageof 119